Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic Gluconeogenesis
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Summary Dynamic regulation of insulin signaling and metabolic gene expression is critical to nutrient homeostasis; dysregulation of these pathways is widely implicated in insulin resistance and other disease states. While the metabolic effects of insulin are well established the components linking insulin signal transduction to a metabolic response are not as well understood. Here, we show that Cdc2-like kinase 2 (Clk2) is a novel insulin regulated suppressor of hepatic gluconeogenesis and glucose output. Clk2 protein levels and kinase activity are induced as part of the hepatic refeeding response by the Insulin/Akt pathway, where Clk2 directly phosphorylates the SR domain on PGC-1α and results in repression of gluconeogenic gene expression and hepatic glucose output. Additionally, Clk2 is down-regulated in db/db mice, re-introduction of Clk2 largely corrects glycemia. Thus, we have identified a novel function and regulation of the Clk2 kinase as a component of hepatic insulin signaling and glucose metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 1×
“MS/MS spectra were assigned by searching them against the GST-Clk2 protein sequence using the SEQUEST algorithm and allowing Ser, Thr, and Tyr residues to be phosphorylated (Eng et al., 1994).”
MethodSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 8×
“The PGC-1a transcriptional coactivator is an important mediator of hepatic fasting metabolism; PGC-1a induces and C maintains expression of the gluconeogenic gene program during fasted states, responding to glucagon/cAMP through CRTC2 (Herzig et al., 2001; Koo et al., 2005; Rhee et al., 2003; Yoon et al., 2001).”
BackgroundSelf-citationInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487 · cited 7×
“The SR domain on PGC1a is a well-documented regulatory region and has been shown to mediate PGC-1a’s insulin responsiveness via interaction with Foxo1 transcription factor and also contain an Akt phosphorylation site (Li et al., 2007; Puigserver et al., 2003).”
BackgroundSelf-citationMolecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865 · cited 1×
“Hepatic gluconeogenesis, the net production of glucose from substrate molecules, is critical for adaptation to fasting conditions and contributes to hyperglycemia in diabetes (Biddinger and Kahn, 2006; Pilkis and Granner, 1992; Quinn and Yeagley, 2005).”
BackgroundNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M. (2004) · Nature Medicine · doi:10.1038/nm1044 · Cited by 550 · cited 2×
“Notably, knockdown of PGC-1a in livers of db/db mice is sufficient to significantly reduce blood glucose levels (Koo et al., 2004), suggesting that hyperactivity of hepatic PGC-1a is a major defect in this insulin-resistant model.”
BackgroundMethodAkt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
Li, X., Monks, B., Ge, Q., & Birnbaum, M. J. (2007) · Nature · doi:10.1038/nature05861 · Cited by 487 · cited 6×
“The SR domain on PGC1a is a well-documented regulatory region and has been shown to mediate PGC-1a’s insulin responsiveness via interaction with Foxo1 transcription factor and also contain an Akt phosphorylation site (Li et al., 2007; Puigserver et al., 2003).”
BackgroundInfluentialHepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis.
Radziuk, J., & Pye, S. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.217 · Cited by 267 · cited 1×
“However, it is known that hepatic gluconeogenesis continues well into the later stages of refeeding (Radziuk and Pye, 2001), suggesting that the suppressive effects of insulin on gluconeogenesis are not immediate and that gluconeogenesis requires several hours to be quantitatively suppressed.”
BackgroundAn unappreciated role for RNA surveillance
Hillman, R. T., Green, R. E., & Brenner, S. E. (2004) · Genome Biology · doi:10.1186/gb-2004-5-2-r8 · Cited by 193 · cited 1×
“They are putative high-level regulators of alternative splicing through phosphorylation of SR domains on splicing factors (Colwill et al., 1996b; Duncan et al., 1995; Hanes et al., 1994; Hillman et al., 2004; Lee et al., 1996; Prasad et al., 1999).”
Background
Cited by
Regulation of pgc-1α, a nodal regulator of mitochondrial biogenesis
Fernandez-Marcos, P. J., & Auwerx, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001917 · Cited by 1,237
PGC-1 α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Rius-Pérez, S., Torres-Cuevas, I., Millán, I., Ortega, Á. L., & Pérez, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1452696 · Cited by 642
Austin, S., & St-Pierre, J. (2012) · Journal of Cell Science · doi:10.1242/jcs.113662 · Cited by 608
Insulin regulation of gluconeogenesis
Hatting, M., Tavares, C. D. J., Sharabi, K., Rines, A. K., & Puigserver, P. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13435 · Cited by 587
Self-citationPGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response
Abu Shelbayeh, O., Arroum, T., Morris, S., & Busch, K. B. (2023) · Antioxidants · doi:10.3390/antiox12051075 · Cited by 552
“In addition, Akt activates CDC2-like kinase 2 (Clk2), which also mediates the PGC-1α inactivation [52].”
Background
Metadata
- Authors
- Rodgers, J. T., Haas, W., Gygi, S. P., & Puigserver, P.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 11
- Issue
- 1
- Pages
- 23-34
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2095473486
- Cited by
- 129
- References
- 10
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic Gluconeogenesis. https://app.cochat.ai/papers/10.1016/j.cmet.2009.11.006
- The paper
- Rodgers, J. T., Haas, W., Gygi, S. P., & Puigserver, P. (2010). Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic Gluconeogenesis. Cell Metabolism. https://doi.org/10.1016/j.cmet.2009.11.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.